 |
| Illumina CEO Jay Flatley |
Illumina ($ILMN) CEO Jay Flatley has shared details of Project Firefly, the genomic leader's move into semiconductor-based sequencing. At a presentation at Advances in Genome Biology and Technology attended by GenomeWeb, Flatley said the sequencing device is a CMOS sensor with nanowells. In early internal tests, the device achieved 99% raw read accuracy, putting it in the same league as the HiSeq X system. Article (reg. req.)
> Big Pharma consortium TransCelerate BioPharma set up a group to share toxicology data. Release
> Israel's Ministry of Health picked Safe-T Box 6.0 to support secure sharing of healthcare data. Statement
> Repositive has secured access to expression data through a partnership with Xpressomics. Item
> Cenduit introduced an interactive response technology system professional services unit. More
> Rondaxe Enterprises released software to help contract manufacturers predict the cost of production projects. Article
> Octapharma picked E-WorkBook 10 from IDBS as its web-based electronic laboratory notebook. Post